Stem announces review of strategic alternatives to maximize shareholder value

STEM•2026-10-26

Stem is reviewing strategic alternatives, including an asset sale, company sale, merger, refinancing or recapitalization. The company engaged Guggenheim Securities as financial advisor and Gibson Dunn & Crutcher and Davis Polk & Wardwell as legal advisors.

1. Strategic review

Stem’s board will consider an asset sale, company sale, merger, refinancing or recapitalization as part of a review of strategic alternatives. Stem engaged Guggenheim Securities as financial advisor and Gibson Dunn & Crutcher and Davis Polk & Wardwell as legal advisors to assist with the review.

Stem announces review of strategic alternatives to maximize shareholder value

1. Strategic review

Related News

Consolidated Water sets third-quarter results conference call

Intrepid Potash's SOP project selected for $139 million in proposed matching funding

S&P Dow Jones partners with Kalshi on index-based event contracts, prediction data

Equillium announces first subject dosed in Phase 1 clinical trial of EQ504

Azitra presents ATR-COSF skin study results at BIO-Europe